Chemotherapy Near the End of Life First-and Third and Fourth (Line)-Do No Harm

被引：12

作者：

Blanke, Charles D. ^{[1
,2
]}

Fromme, Erik K. ^{[1
,2
,3
]}

机构：

[1] Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR USA

[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[3] Oregon Hlth & Sci Univ, Palliat Care Serv, Portland, OR 97201 USA

来源：

JAMA ONCOLOGY | 2015年 / 1卷 / 06期

关键词：

CELL LUNG-CANCER;

D O I：

10.1001/jamaoncol.2015.2379

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：785 / 786

页数：2

共 6 条

[1] Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study [J].

Christakis, NA ;

Lamont, EB .

BRITISH MEDICAL JOURNAL, 2000, 320 (7233) :469-472

[2] Losing "Losing the Battle With Cancer" [J].

Ellis, Lee M. ;

Blanke, Charles D. ;

Roach, Nancy .

JAMA ONCOLOGY, 2015, 1 (01) :13-14

[3] A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer [J].

Massarelli, E ;

Andre, F ;

Liu, DD ;

Lee, JJ ;

Wolf, M ;

Fandi, A ;

Ochs, J ;

Le Chevalier, T ;

Fossella, F ;

Herbst, RS .

LUNG CANCER, 2003, 39 (01) :55-61

[4] Prognostic Significance of the "Surprise'' Question in Cancer Patients [J].

Moss, Alvin H. ;

Lunney, June R. ;

Culp, Stacey ;

Auber, Miklos ;

Kurian, Sobha ;

Rogers, John ;

Dower, Joshua ;

Abraham, Jame .

JOURNAL OF PALLIATIVE MEDICINE, 2010, 13 (07) :837-840

[5]

Prigerson HG, 2015, JAMA ONCOL, DOI 101001/jamaoncol.2015.2378

[6] Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews [J].

Silvestri, G ;

Pritchard, R ;

Welch, HG .

BRITISH MEDICAL JOURNAL, 1998, 317 (7161) :771-775

← 1 →